| Robert Jason Caughey, MD | |
|
3341 Beale Ave, Altoona, PA 16601-1549 | |
| (814) 944-5357 | |
| (814) 946-8017 |
| Full Name | Robert Jason Caughey |
|---|---|
| Gender | Male |
| Speciality | Otolaryngology |
| Experience | 22 Years |
| Location | 3341 Beale Ave, Altoona, Pennsylvania |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1265503197 | NPI | - | NPPES |
| 1019045700001 | Medicaid | PA | |
| CA1956813 | Other | BLUE SHIELD | |
| P00400431 | Other | PA | MEDICARE RAILROAD |
| MD430275 | Other | PA | STATE LICENSE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Y00000X | Otolaryngology | MD430275 (Pennsylvania) | Primary |
| 207YX0007X | Otolaryngology - Plastic Surgery Within The Head & Neck | MD430275 (Pennsylvania) | Secondary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Nason Medical Center, Llc | Roaring spring, PA | Hospital |
| Upmc Altoona | Altoona, PA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Ear Nose And Throat Associates Of Central Pa Pc | 3274832027 | 4 |
News Archive
Spirogen, a leading oncology-focused company developing DNA sequence targeted agents, and BioAtla LLC, a San Diego headquartered antibody therapeutics developer, today announced new data on the use of pyrrolobenzodiazepine (PBD) dimers as warheads in antibody drug conjugates (ADCs) at the annual meeting of the American Association for Cancer Research (AACR) in Washington, DC.
UCLA researchers examining outcomes for advanced heart-failure patients over the past two decades have found that, coinciding with the increased availability and use of new therapies, overall mortality has decreased and sudden cardiac death, caused by the rapid onset of severe abnormal heart rhythms, has declined.
Investigators have developed a new mathematical approach to analyze molecular data derived from complex mixtures of immune cells. This approach, when combined with well-established techniques, readily identifies changes in small samples of human whole blood, and has the potential to distinguish between health and disease states.
A Ludwig Cancer Research study has identified and preclinically validated combination treatments for the brain metastases of breast cancer, a common and typically lethal manifestation of the malignancy.
› Verified 3 days ago
| Entity Name | Ear Nose And Throat Associates Of Central Pa Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1053345397 PECOS PAC ID: 3274832027 Enrollment ID: O20160428001059 |
News Archive
Spirogen, a leading oncology-focused company developing DNA sequence targeted agents, and BioAtla LLC, a San Diego headquartered antibody therapeutics developer, today announced new data on the use of pyrrolobenzodiazepine (PBD) dimers as warheads in antibody drug conjugates (ADCs) at the annual meeting of the American Association for Cancer Research (AACR) in Washington, DC.
UCLA researchers examining outcomes for advanced heart-failure patients over the past two decades have found that, coinciding with the increased availability and use of new therapies, overall mortality has decreased and sudden cardiac death, caused by the rapid onset of severe abnormal heart rhythms, has declined.
Investigators have developed a new mathematical approach to analyze molecular data derived from complex mixtures of immune cells. This approach, when combined with well-established techniques, readily identifies changes in small samples of human whole blood, and has the potential to distinguish between health and disease states.
A Ludwig Cancer Research study has identified and preclinically validated combination treatments for the brain metastases of breast cancer, a common and typically lethal manifestation of the malignancy.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Robert Jason Caughey, MD 3341 Beale Ave, Altoona, PA 16601-1549 Ph: (814) 944-5357 | Robert Jason Caughey, MD 3341 Beale Ave, Altoona, PA 16601-1549 Ph: (814) 944-5357 |
News Archive
Spirogen, a leading oncology-focused company developing DNA sequence targeted agents, and BioAtla LLC, a San Diego headquartered antibody therapeutics developer, today announced new data on the use of pyrrolobenzodiazepine (PBD) dimers as warheads in antibody drug conjugates (ADCs) at the annual meeting of the American Association for Cancer Research (AACR) in Washington, DC.
UCLA researchers examining outcomes for advanced heart-failure patients over the past two decades have found that, coinciding with the increased availability and use of new therapies, overall mortality has decreased and sudden cardiac death, caused by the rapid onset of severe abnormal heart rhythms, has declined.
Investigators have developed a new mathematical approach to analyze molecular data derived from complex mixtures of immune cells. This approach, when combined with well-established techniques, readily identifies changes in small samples of human whole blood, and has the potential to distinguish between health and disease states.
A Ludwig Cancer Research study has identified and preclinically validated combination treatments for the brain metastases of breast cancer, a common and typically lethal manifestation of the malignancy.
› Verified 3 days ago
David Earl Higgins, M.D. Otolaryngology Medicare: Medicare Enrolled Practice Location: 3341 Beale Ave, Altoona, PA 16601 Phone: 814-944-5357 Fax: 814-946-8017 | |
Ramesh Agarwal, Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 716 24th St, Suite 3100, Altoona, PA 16602 Phone: 814-944-3031 | |
Richard Charles Howells Ii, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 3341 Beale Ave, Altoona, PA 16601 Phone: 814-944-5357 Fax: 814-946-8017 |